Andrew Huberman· PhD
Blood Markers, ApoB, Cholesterol, Tool: Test Don’t Guess, Individualization
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Blood Markers, ApoB, Cholesterol, Tool: Test Don’t Guess, Individualization
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Yeah, I think that's, you know, a reductionist thinking that, yeah, we got to have, you know, what we were born with, but it is one of those things where, you know, I treat the individual sitting in front of me. I'm not doing population-based medicine. Yeah, if you take all comers with, you know, an apoB of 180, well, a good chunk of them are going to have, you know, plaque in their left anterior descending, and some of them won't.